![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of the Pangenotypic HCV NS3/4A Protease
Inhibitor GS-9857 in Healthy Volunteers
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Brian J. Kirby, Jenny C. Yang, Chris Yang, Qinghua Song, Yi Wang, James G. Taylor, Luisa M. Stamm, Anita Mathias
Gilead Sciences, Inc., Foster City, California, USA
![EASL1.gif](../images/042915/042915-8/EASL1.gif)
![EASL2.gif](../images/042915/042915-8/EASL2.gif)
![EASL3.gif](../images/042915/042915-8/EASL3.gif)
![EASL4.gif](../images/042915/042915-8/EASL4.gif)
![EASL5.gif](../images/042915/042915-8/EASL5.gif)
![EASL6.gif](../images/042915/042915-8/EASL6.gif)
![EASL7.gif](../images/042915/042915-8/EASL7.gif)
![EASL8.gif](../images/042915/042915-8/EASL8.gif)
![EASL9.gif](../images/042915/042915-8/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|